Bio-Techne
TECH
#1805
Rank
A$16.23 B
Marketcap
A$103.40
Share price
-0.07%
Change (1 day)
11.26%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): A$1.72

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is A$1.67. In 2025 the company made an earnings per share (EPS) of A$0.74 a decrease over its 2024 EPS that were of A$1.42.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.72132.38%
2025A$0.74-48%
2024A$1.42-29.58%
2023A$2.02-14.97%
2022A$2.3824.16%
2021A$1.9117.98%
2020A$1.62-10.94%
2019A$1.82101.57%
2018A$0.90-16.99%
2017A$1.0945.02%
2016A$0.75-20.97%
2015A$0.95-14.97%
2014A$1.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$26.50 1,491.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$5.12 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$12.18 631.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$8.04 382.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$2.82 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
A-$0.30-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$11.85 611.97%๐Ÿ‡บ๐Ÿ‡ธ USA